NCT07483268进行中（未招募）不适用
A Prospective Study of Stapokibart Injection in Patients With CRSwNP
Chengdu Kangnuoxing Biopharma,Inc.1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2026年5月29日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 600
- 试验地点
- 1
研究概览
简要总结
This study is a open label, prospective study to evaluate the safety of Stapokibart Injection in subjects with CRSwNP.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Participants aged 18 years or older at the time of informed consent and provide voluntary informed consent to participate in the study before inclusion in the study.
- •Physician decision to treat the participant with Stapokibart Injection for CRSwNP (according to the China-specific prescribing information) made prior to and independently of the participant's participation in the study.
排除标准
- •Known history of allergic reaction to Stapokibart Injection.
- •Participants currently or plan participating in any interventional clinical trial.
- •Participants with hematologic malignancies.
- •Women with pregnant.
- •Any condition that, in the opinion of the Investigator, may interfere with the participant's ability to participate in the study.
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
A Prospective Study of Stapokibart Injection in Patients With Seasonal Allergic Rhinitis (SAR)NCT07459556Chengdu Kangnuoxing Biopharma,Inc.400
招募中
不适用
A Study of Stapokibart Injection in Patients With Atopic Dermatitis (AD)Atopic Dermatitis (AD)NCT07544862Chengdu Kangnuoxing Biopharma,Inc.1,000
招募中
2 期
A Phase II Clinical Study of SKB571 as Monotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With MET AbnormalitiesNCT07308106Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.70
尚未招募
不适用
Using Injectable Platelet-Rich Fibrin (i-PRF) to Treat Under-Eye Aging: A Clinical StudyCTRI/2026/04/107424Datta Meghe Medical College25
招募中
不适用
A comparative study to evaluate the insertion of postpartum intrauterine contraceptive device with the new inserter versus Kelly forceps .CTRI/2024/08/072917Dr Palak60